| 5NX1 | date | ![]() |
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||||||
| compound | source | ||||||||||||||||||
| symmetry |
| ||||||||||||||||||
| crystal cell |
| ||||||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||||||
| Gene Ontology |
| ||||||||||||||||||
| Primary reference | A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering., Sananes A, Cohen I, Shahar A, Hockla A, De Vita E, Miller AK, Radisky ES, Papo N, J Biol Chem. 2018 Aug 17;293(33):12663-12680. doi: 10.1074/jbc.RA117.000871. Epub, 2018 Jun 22. PMID:29934309 | ||||||||||||||||||
| Data retrieval |
![]() |
| View 5NX1 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |